CA
NZ
UK
AU
IND
US
Cost of revenue fell to USD 10.0 million from USD 14.7 million.Research and Developmentexpense was USD 99.1 million, a decrease of USD 21.9 million, or 18%, from USD 121.1 million. The company also revised its research and development breakout in light of the evolving …
Site leasing revenue was USD 665.4 million, up 1.4%, while site development revenue fell 36.0% to USD 48.5 million. Adjusted EBITDA was USD 488.1 million, down 1.1%, thoughMarginrose to 68.8% from 67.5%. TowerCash Flowwas USD 526.9 million, and AFFO was USD 337.3 million, down …
Expenses were USD 214.9 million versus USD 162.0 million.Depreciationand amortization rose to USD 64.8 million from USD 48.5 million, interest expense was USD 29.2 million versus USD 28.9 million, senior housing operating portfolio expenses rose to USD 99.3 million from USD 65.9 million, and …
Gross profit was USD 44.2 million, up 13.7%, and grossMarginwas 79.3% versus 79.8%, reflecting procedure and site-of-care mix. Operating expenses rose 9.7% to USD 48.5 million from USD 44.2 million on sales commissions,Marketingfor new product launches and research and development. The operating loss improved …
Impairment charges were USD 2.0 million versus USD 106.6 million, and general and administrative expense was USD 9.0 million versus USD 10.3 million. Total expenses were USD 15.8 million versus USD 137.0 million. Interest expense was nil versus USD 3.9 million, and interest income …
Cost of product sales was USD 14.0 million versus USD 2.1 million, so by our calculation product grossMarginwas about 77% versus 93%.Research and Developmentexpense was USD 67.5 million versus USD 56.3 million, and selling, general and administrative expense was USD 43.7 million versus USD …
Cost of revenue rose 3% to USD 21.4 million, andGross Profitwas USD 70.5 million versus USD 65.0 million. Gross margin was 77% versus 76%, and management cited an expansion of 90 basis points to 76.7%, the twelfth consecutive quarter of year-over-year improvement.
Adjusted EBITDA was USD 48.8 million versus USD 49.8 million, a margin of 15.1% versus 16.4%. Higher volume, pricing andTariffrefunds were more than offset by inflationary cost pressures, part availability constraints and higher selling, administrative and research costs, including ERP-related costs and robotics investment. …
Net profit was USD 120 million, a 23% net margin compared with 14% a year earlier, or 2.2 times the prior-year figure.Earnings Per Sharewere USD 1.06 basic and USD 1.05 diluted, compared with USD 0.48 basic and USD 0.47 diluted.
Gross profit therefore slipped to USD 35.1 million from USD 36.4 million, which by our calculation is aMarginof 20.9% versus 23.7%. General and administrative expense was USD 25.4 million versus USD 25.2 million, and operating income was USD 9.7 million versus USD 11.1 million.
Please wait processing your request...